Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
11,621
+744
+7% +$85.9K 0.05% 312
2026
Q1
$1.3M Buy
10,877
+397
+4% +$52.1K 0.06% 294
2025
Q4
$1.43M Buy
10,480
+1,379
+15% +$198K 0.07% 256
2025
Q3
$1.34M Sell
9,101
-89
-1% -$12.3K 0.07% 257
2025
Q2
$1.19M Buy
9,190
+275
+3% +$33.3K 0.07% 254
2025
Q1
$1.06M Sell
8,915
-1,587
-15% -$197K 0.07% 290
2024
Q4
$1.22M Buy
10,502
+593
+6% +$75K 0.08% 248
2024
Q3
$1.34M Buy
9,909
+69
+0.7% +$9.23K 0.09% 227
2024
Q2
$1.33M Buy
9,840
+754
+8% +$103K 0.1% 202
2024
Q1
$1.17M Buy
9,086
+1,188
+15% +$144K 0.07% 297
2023
Q4
$903K Buy
7,898
+135
+2% +$13.5K 0.17% 143
2023
Q3
$707K Buy
7,763
+56
+0.7% +$5.78K 0.13% 170
2023
Q2
$868K Sell
7,707
-60
-0.8% -$6.34K 0.15% 144
2023
Q1
$813K Buy
+7,767
New +$811K 0.17% 136

Other funds holding XYL

PFG Investments's XYL Position: Q2 2026 in Review

PFG Investments increased its Xylem (XYL) stake by 6.8% in Q2 2026, buying an estimated $85.9K and bringing the position to 11,621 shares worth $1.37M. The position accounts for 0.05% of the portfolio, ranked #312.

PFG Investments first reported a position in XYL in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.43M in Q4 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • PFG Investments held 11,621 shares of Xylem worth $1.37M as of Q2 2026.
  • PFG Investments bought 744 Xylem shares in Q2 2026, an estimated $85.9K.
  • Xylem made up 0.05% of PFG Investments's portfolio in Q2 2026, its #312 holding.
  • PFG Investments first reported a position in Xylem in Q1 2023 and has held it in 14 quarters since.
  • PFG Investments's Xylem position peaked at $1.43M in Q4 2025.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.